Vera Therapeutics
VERA

Vera Therapeutics (VERA) earnings history

Most recent quarter

Period end
Jun 30, 2025
EPS actual
−$1.20
EPS estimate
−$0.82
EPS surprise
−46.06%
Revenue
$0.00
Reported
Aug 5, 2025

Earnings history

PeriodReportedEPS estimateEPS actualSurpriseRevenueFiling
Q2 2025Aug 5, 2025−$0.82−$1.20−46.06%$0.00SEC
Q1 2025May 6, 2025−$0.74−$0.81−9.27%$0.00SEC
Q4 2024Feb 26, 2025−$0.81−$0.72+11.35%$0.00SEC
Q3 2024Nov 7, 2024−$0.64−$0.85−33.33%$0.00SEC
Q2 2024Aug 8, 2024−$0.56−$0.62−10.71%$0.00SEC
Q1 2024May 9, 2024−$0.53−$0.56−5.58%$0.00SEC
Q4 2023Mar 20, 2024−$0.50−$0.54−6.99%$0.00SEC
Q3 2023Nov 9, 2023−$0.52−$0.45+13.24%$0.00SEC
Q2 2023Aug 10, 2023−$0.65−$0.46+29.60%$0.00SEC
Q1 2023May 11, 2023−$0.57−$0.80−40.62%$0.00SEC
Q4 2022Mar 28, 2023−$0.86−$1.17−35.31%$0.00SEC
Q3 2022Nov 9, 2022−$0.70−$0.91−30.02%$0.00SEC
Q2 2022Aug 10, 2022−$0.68−$0.55+18.91%$0.00SEC
Q1 2022May 16, 2022−$0.63−$0.71−12.11%$0.00SEC
Q4 2021Mar 24, 2022−$0.45−$0.79−74.28%$0.00SEC
Q3 2021Nov 10, 2021−$0.69−$0.36+47.58%$0.00SEC
Q2 2021Aug 16, 2021−$0.39−$0.33+15.38%$0.00SEC
Q1 2021Jun 24, 2021−$1.95−$12.23−528.79%$0.00

Quarterly revenue

Q1 2021
$0.00
Q2 2021
$0.00
Q3 2021
$0.00
Q4 2021
$0.00
Q1 2022
$0.00
Q2 2022
$0.00
Q3 2022
$0.00
Q4 2022
$0.00
Q1 2023
$0.00
Q2 2023
$0.00
Q3 2023
$0.00
Q4 2023
$0.00
Q1 2024
$0.00
Q2 2024
$0.00
Q3 2024
$0.00
Q4 2024
$0.00
Q1 2025
$0.00
Q2 2025
$0.00

Frequently asked questions

  • When did Vera Therapeutics (VERA) last report earnings?

    Vera Therapeutics last reported on Aug 5, 2025, covering fiscal Q2 2025.

  • Did VERA beat earnings estimates?

    No. Vera Therapeutics reported EPS of −$1.20 for Q2 2025 against a −$0.82 estimate — a 46.06% miss.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.